These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 490684)
1. Note on the metabolism of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate. Gabard B; Walser R J Toxicol Environ Health; 1979 Jul; 5(4):759-64. PubMed ID: 490684 [TBL] [Abstract][Full Text] [Related]
2. In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate. Stewart JR; Diamond GL Drug Metab Dispos; 1988; 16(2):189-95. PubMed ID: 2898331 [TBL] [Abstract][Full Text] [Related]
3. Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit. Maiorino RM; Weber GL; Aposhian HV Drug Metab Dispos; 1988; 16(3):455-63. PubMed ID: 2900740 [TBL] [Abstract][Full Text] [Related]
4. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate. Cherian MG; Miles EF; Clarkson TW; Cox C J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303 [TBL] [Abstract][Full Text] [Related]
5. The effect of 2,3-dimercaptopropane sodium sulfonate on mercury retention in rats in relation to age. Kostial K; Kargacin B; Blanusa M; Landeka M Arch Toxicol; 1984 Oct; 55(4):250-2. PubMed ID: 6517703 [TBL] [Abstract][Full Text] [Related]
6. Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans. Maiorino RM; Dart RC; Carter DE; Aposhian HV J Pharmacol Exp Ther; 1991 Nov; 259(2):808-14. PubMed ID: 1941628 [TBL] [Abstract][Full Text] [Related]
7. The excretion of trace elements in rat urine after treatment with 2,3-dimercaptopropane sodium sulfonate. Gabard B; Planas-Bohne F; Regula G Toxicology; 1979; 12(3):281-4. PubMed ID: 494309 [TBL] [Abstract][Full Text] [Related]
8. Removal of internally deposited gold by 2,3-dimercaptopropane sodium sulphonate (Dimaval). Gabard B Br J Pharmacol; 1980 Apr; 68(4):607-10. PubMed ID: 7378634 [TBL] [Abstract][Full Text] [Related]
9. Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney. Klotzbach JM; Diamond GL Am J Physiol; 1988 Jun; 254(6 Pt 2):F871-8. PubMed ID: 3381889 [TBL] [Abstract][Full Text] [Related]
10. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney. Diamond GL; Klotzbach JM; Stewart JR J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658 [TBL] [Abstract][Full Text] [Related]
11. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. Gonzalez-Ramirez D; Zuniga-Charles M; Narro-Juarez A; Molina-Recio Y; Hurlbut KM; Dart RC; Aposhian HV J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315 [TBL] [Abstract][Full Text] [Related]
12. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury. Zalups RK J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154 [TBL] [Abstract][Full Text] [Related]
13. Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers. Hurlbut KM; Maiorino RM; Mayersohn M; Dart RC; Bruce DC; Aposhian HV J Pharmacol Exp Ther; 1994 Feb; 268(2):662-8. PubMed ID: 8113976 [TBL] [Abstract][Full Text] [Related]
14. Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children. Chisolm JJ; Thomas DJ J Pharmacol Exp Ther; 1985 Dec; 235(3):665-9. PubMed ID: 4078728 [TBL] [Abstract][Full Text] [Related]
15. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789 [TBL] [Abstract][Full Text] [Related]
16. Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier mediated transport. Wildenauer DB; Reuther H; Weger N Chem Biol Interact; 1982 Nov; 42(2):165-77. PubMed ID: 7151227 [TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of trace elements in humans after sodium 2,3-dimercaptopropane-1-sulfonate challenge test. Torres-Alanís O; Garza-Ocañas L; Bernal MA; Piñeyro-López A J Toxicol Clin Toxicol; 2000; 38(7):697-700. PubMed ID: 11192456 [TBL] [Abstract][Full Text] [Related]
18. Chelation of lead by dimercaptopropane sulfonate and a possible diagnostic use. Twarog T; Cherian MG Toxicol Appl Pharmacol; 1984 Mar; 72(3):550-6. PubMed ID: 6710504 [TBL] [Abstract][Full Text] [Related]
19. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride. Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Aposhian MM; Dart RC; Woods JS; Ostrosky-Wegman P; Gonsebatt ME; Aposhian HV J Pharmacol Exp Ther; 1996 May; 277(2):938-44. PubMed ID: 8627576 [TBL] [Abstract][Full Text] [Related]
20. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden. Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]